se ha leído el artículo
array:25 [ "pii" => "S0211699517301339" "issn" => "02116995" "doi" => "10.1016/j.nefro.2017.05.010" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "398" "copyright" => "Sociedad Española de Nefrología" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Nefrologia. 2018;38:87-91" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4762 "formatos" => array:3 [ "EPUB" => 445 "HTML" => 3402 "PDF" => 915 ] ] "Traduccion" => array:1 [ "en" => array:20 [ "pii" => "S201325141830021X" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2017.05.017" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "398" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Nefrologia (English Version). 2018;38:87-91" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1991 "formatos" => array:3 [ "EPUB" => 234 "HTML" => 1244 "PDF" => 513 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>" "titulo" => "Hyponatremia in refractory congestive heart failure patients treated with icodextrin-based peritoneal dialysis: A case series" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "87" "paginaFinal" => "91" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hiponatremia en pacientes con insuficiencia cardíaca congestiva resistentes al tratamiento tratados con diálisis peritoneal con icodextrina: una serie de casos" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Margarita Kunin, Liat Ganon, Eli J. Holtzman, Dganit Dinour" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Margarita" "apellidos" => "Kunin" ] 1 => array:2 [ "nombre" => "Liat" "apellidos" => "Ganon" ] 2 => array:2 [ "nombre" => "Eli J." "apellidos" => "Holtzman" ] 3 => array:2 [ "nombre" => "Dganit" "apellidos" => "Dinour" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0211699517301339" "doi" => "10.1016/j.nefro.2017.05.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699517301339?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S201325141830021X?idApp=UINPBA000064" "url" => "/20132514/0000003800000001/v1_201802180616/S201325141830021X/v1_201802180616/en/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S0211699517300127" "issn" => "02116995" "doi" => "10.1016/j.nefro.2016.12.004" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "329" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia. 2018;38:92-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4375 "formatos" => array:3 [ "EPUB" => 306 "HTML" => 3359 "PDF" => 710 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Infiltración renal linfomatosa en paciente con síndrome nefrótico" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "92" "paginaFinal" => "94" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Renal lymphomatous infiltration in patient with nefrotic syndrome" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1084 "Ancho" => 1417 "Tamanyo" => 486948 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Características histológicas de los infiltrados linfoides que afectaban tanto al parénquima renal (A: H&E, ×10) como al tejido perirrenal (B: H&E, ×10). El infiltrado linfoide destruía el parénquima dejando aislados túbulos residuales con dudosas imágenes de lesión linfoepitelial (C: H&E, ×20). La celularidad era monomorfa, de pequeño tamaño, contorno nuclear irregular, con nucléolo poco evidente y sin actividad mitótica significativa (D: H&E, ×40).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Enoc Merino García, María Pilar Pérez del Barrio, Josefa Borrego Hinojosa, Francisco J. Borrego Utiel, María Carmen Sánchez Perales" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Enoc" "apellidos" => "Merino García" ] 1 => array:2 [ "nombre" => "María Pilar" "apellidos" => "Pérez del Barrio" ] 2 => array:2 [ "nombre" => "Josefa" "apellidos" => "Borrego Hinojosa" ] 3 => array:2 [ "nombre" => "Francisco J." "apellidos" => "Borrego Utiel" ] 4 => array:2 [ "nombre" => "María Carmen" "apellidos" => "Sánchez Perales" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2013251417301712" "doi" => "10.1016/j.nefroe.2017.10.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417301712?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699517300127?idApp=UINPBA000064" "url" => "/02116995/0000003800000001/v1_201801090621/S0211699517300127/v1_201801090621/es/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S0211699517300966" "issn" => "02116995" "doi" => "10.1016/j.nefro.2017.03.023" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "376" "copyright" => "Sociedad Española de Nefrología" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2018;38:79-86" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6428 "formatos" => array:3 [ "EPUB" => 281 "HTML" => 5392 "PDF" => 755 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original breve</span>" "titulo" => "Efectos de la rotigotina sobre la sintomatología, calidad de vida e higiene de sueño en el síndrome de piernas inquietas en hemodiálisis" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "79" "paginaFinal" => "86" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Effects of rotigotine on clinical symptoms, quality of life and sleep hygiene adequacy in haemodialysis-associated restless legs syndrome" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1061 "Ancho" => 1677 "Tamanyo" => 61053 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Principal etiología de la enfermedad renal crónica en pacientes con SPI en HD. Resultados expresados en porcentajes (%).</p> <p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">DM: diabetes mellitus; Enf. AE: enfermedad ateroembólica; Enf. glomerular 1.ª: enfermedad glomerular primaria; HTA: hipertensión arterial; Nefropatía T-I: nefropatía tubulointersticial; SPI: síndrome de piernas inquietas.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Vicent Esteve, Jose Carneiro, Gabriel Salazar, Mónica Pou, Irati Tapia, Miquel Fulquet, Verónica Duarte, Anna Saurina, Fátima Moreno, Manel Ramírez de Arellano" "autores" => array:10 [ 0 => array:2 [ "nombre" => "Vicent" "apellidos" => "Esteve" ] 1 => array:2 [ "nombre" => "Jose" "apellidos" => "Carneiro" ] 2 => array:2 [ "nombre" => "Gabriel" "apellidos" => "Salazar" ] 3 => array:2 [ "nombre" => "Mónica" "apellidos" => "Pou" ] 4 => array:2 [ "nombre" => "Irati" "apellidos" => "Tapia" ] 5 => array:2 [ "nombre" => "Miquel" "apellidos" => "Fulquet" ] 6 => array:2 [ "nombre" => "Verónica" "apellidos" => "Duarte" ] 7 => array:2 [ "nombre" => "Anna" "apellidos" => "Saurina" ] 8 => array:2 [ "nombre" => "Fátima" "apellidos" => "Moreno" ] 9 => array:2 [ "nombre" => "Manel" "apellidos" => "Ramírez de Arellano" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2013251417302079" "doi" => "10.1016/j.nefroe.2017.11.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417302079?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699517300966?idApp=UINPBA000064" "url" => "/02116995/0000003800000001/v1_201801090621/S0211699517300966/v1_201801090621/es/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>" "titulo" => "Hyponatremia in refractory congestive heart failure patients treated with icodextrin-based peritoneal dialysis: A case series" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "87" "paginaFinal" => "91" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Margarita Kunin, Liat Ganon, Eli J. Holtzman, Dganit Dinour" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Margarita" "apellidos" => "Kunin" "email" => array:1 [ 0 => "Margarita.Kunin@sheba.health.gov.il" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Liat" "apellidos" => "Ganon" ] 2 => array:2 [ "nombre" => "Eli J." "apellidos" => "Holtzman" ] 3 => array:2 [ "nombre" => "Dganit" "apellidos" => "Dinour" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Nephrology and Hypertension Institute, Sheba Medical Center and Sackler Faculty of Medicine, Tel-Hashomer, Israel" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hiponatremia en pacientes con insuficiencia cardíaca congestiva resistentes al tratamiento tratados con diálisis peritoneal con icodextrina: una serie de casos" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Removal of extensive fluid overload is one of the most difficult challenges in the management of severe congestive heart failure (CHF), particularly in patients who do not respond to diuretic therapy. Peritoneal ultrafiltration (UF) is a simple choice for daily fluid removal. Today, peritoneal dialysis (PD) is increasingly used to treat hypervolemic CHF patients who are resistant to conventional therapies, in particular when complicated by renal insufficiency (reviewed in Refs. <a class="elsevierStyleCrossRefs" href="#bib0095">1, 2</a>). Icodextrin was proposed to be a good option for UF in refractory CHF patients.<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">3–6</span></a> Icodextrin solution is a long-acting osmotic agent that allows the patient's UF volume to gradually increase for up to 12<span class="elsevierStyleHsp" style=""></span>h.<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">1,3</span></a> In a recently published systematic review<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">7</span></a> it was found that mortality in CHF patients treated with peritoneal UF was associated with less use of icodextrin.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Icodextrin is generally well tolerated. A small, although statistically significant reduction in serum sodium (∼2<span class="elsevierStyleHsp" style=""></span>mmol/l) consistently observed in multiple trials, is likely not clinically relevant.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">8</span></a> Two female diabetic patients treated by icodextrin-based PD developed severe hyponatraemia with plasma Na<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>121<span class="elsevierStyleHsp" style=""></span>mmol/l and neurological complications.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">9</span></a> The mechanism by which icodextrin causes hyponatremia is unclear. It was proposed that icodextrin solution leads to accumulation of maltose in the extracellular volume and this gradient induces osmotic flow by a mechanism similar to isosmolar colloid osmosis. The resultant shift in water from the intracellular to the extracellular space can result in dilutional hyponatremia.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">8</span></a> It was demonstrated that icodextrin increased peritoneal Na removal.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">10</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Five refractory CHF patients treated with peritoneal ultrafiltration in our unit, developed significant symptomatic hyponatremia with Na<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>130<span class="elsevierStyleHsp" style=""></span>mmol/l after icodextrin was added to their program (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Cases description</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Patient 1</span><p id="par0020" class="elsevierStylePara elsevierViewall">A 63-year-old woman with history of diabetes mellitus (DM), restrictive cardiomyopathy and severe pulmonary hypertension was referred to PD due to significant volume overload. Her eGFR was 27<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span>. She had no proteinuria and renal sonography showed small kidneys. Her kidney disease was attributed to nephrosclerosis with cardiorenal component. She was treated with one dianeal glucose solution 4.25% exchange per day for 6 weeks, then icodextrin was added to her program. She continued the treatment with furosemide and was on sodium restriction diet. Her urinary sodium at icodextrin start was 78<span class="elsevierStyleHsp" style=""></span>meq/l. Following icodextrin start a serum sodium dropped from 136.3 to 128.3<span class="elsevierStyleHsp" style=""></span>meq/l (average of 3 consecutive values) with the lowest value measured of 126<span class="elsevierStyleHsp" style=""></span>meq/l. The patient complained of extreme weakness and fatigue. Icodextrin was stopped and dianeal glucose solution 2.5% was started. After icodextrin stop serum sodium raised to 134.7<span class="elsevierStyleHsp" style=""></span>meq/l (average of 3 consecutive values). Due to difficulty to maintain adequate ultrafiltration and worsening diabetes mellitus control, icodextrin was restarted. Serum sodium dropped to 128.7<span class="elsevierStyleHsp" style=""></span>meq/l (average of 3 consecutive values), lowest value measured was 128<span class="elsevierStyleHsp" style=""></span>meq/l. The patient complained of extreme weakness and fatigue, therefore icodextrin was stopped again. A month later average serum sodium was 133<span class="elsevierStyleHsp" style=""></span>meq/l. The patient died a month later from heart failure exacerbation.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Patient 2</span><p id="par0025" class="elsevierStylePara elsevierViewall">A 64-year-old woman with hypertrophic cardiomyopathy was referred to PD due to significant volume overload. She had no proteinuria and demonstrated normal kidneys in renal sonography. Her kidney disease was attributed to cardiorenal syndrome. At PD start the patient's eGFR was 23<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span>. From the very beginning she turned to be hypotensive and oliguric. The patient was 8 months on PD with 3 glucose 2.5% exchanges per day. Furosemide was stopped due to oliguria and hypotension. Urinary sodium was 49<span class="elsevierStyleHsp" style=""></span>meq/l and the patient continued to be edematous. After icodextrin addition serum sodium dropped from 133.7 to 126.3<span class="elsevierStyleHsp" style=""></span>meq/l (average of 3 consecutive values) with the lowest value measured of 125<span class="elsevierStyleHsp" style=""></span>meq/l. The patient continued with icodextrin despite low serum sodium. Non-adherence to free water restriction was suspected. Despite the attempts to restrict free water consumption by the patient serum sodium remained low. The patient died 5 months later from septic shock due to infected cardiac pacemaker electrode.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Patient 3</span><p id="par0030" class="elsevierStylePara elsevierViewall">An 82-year-old man with ischemic cardiomyopathy and low LVEF started PD due to resistant volume overload. At the admission his eGFR was 26<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span>. He had non-nephrotic proteinuria and reduced parenchyma size in kidney sonography. His renal disease was attributed to nephrosclerosis with cardiorenal component. He was treated with PD for one month with 2 exchanges per day: glucose 2.5% and glucose 4.25%. He continued treatment with furosemide and was on sodium restriction diet. His urinary sodium was 53<span class="elsevierStyleHsp" style=""></span>meq/l. After icodextrin addition serum sodium dropped from 134.7 to 129.3<span class="elsevierStyleHsp" style=""></span>meq/l (average of 3 consecutive values) with the lowest value measured of 127<span class="elsevierStyleHsp" style=""></span>meq/l. The patient continued with icodextrin despite low serum sodium. He was diagnosed with hip fracture without the history of trauma or fall. He did not recover from the surgery and eventually died in the hospital.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Patient 4</span><p id="par0035" class="elsevierStylePara elsevierViewall">A 75-year-old woman with severe primary pulmonary hypertension and cardiorenal syndrome started PD due to resistant volume overload. At the admission her eGFR was 36<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span>. The patient was treated with one glucose 4.25% exchange per day for 2 months. She was edematous therefore icodextrin was added. She continued treatment with furosemide and was on sodium restriction diet. Her urinary sodium was 26<span class="elsevierStyleHsp" style=""></span>meq/l. After icodextrin start serum sodium dropped from 137.3 to 129<span class="elsevierStyleHsp" style=""></span>meq/l (average of 3 consecutive values) with the lowest value measured of 128<span class="elsevierStyleHsp" style=""></span>meq/l. She was reported by her family to be confused. She fell down and broke her hip neck. Icodextrin was stopped during the hospitalization. A month later average serum sodium was 138<span class="elsevierStyleHsp" style=""></span>meq/l (average of 3 consecutive values). The patient eventually died from complications of orthopedic surgery.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Patient 5</span><p id="par0040" class="elsevierStylePara elsevierViewall">An 85-year-old man with ischemic cardiomyopathy, low LVEF, severe pulmonary hypertension and diabetes mellitus started with peritoneal UF due to refractory volume overload. His eGFR was 43<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span> at PD start. He had no proteinuria and normal kidneys in sonography. His kidney disease was attributed to cardiorenal syndrome. He was treated with one glucose 4.25% exchange per day for 3 month, then icodextrin was added. He continued treatment with furosemide and was on sodium restriction diet. His urinary sodium was 31<span class="elsevierStyleHsp" style=""></span>meq/l. After icodextrin start serum sodium dropped from 138.3 to 130<span class="elsevierStyleHsp" style=""></span>meq/l (average of 3 consecutive values) with the lowest value measured of 127<span class="elsevierStyleHsp" style=""></span>meq/l. Icodextrin was stopped. A month later serum sodium was 138.6<span class="elsevierStyleHsp" style=""></span>meq/l (average of 3 consecutive values).</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Comparison of severe hyponatremia group with mild hyponatremia group</span><p id="par0045" class="elsevierStylePara elsevierViewall">To find out which patients were more susceptible to severe hyponatremia after icodextrin addition we compared the characteristics of the above 5 patients as a group (median serum sodium was 129<span class="elsevierStyleHsp" style=""></span>meq/l, range 126.3–130<span class="elsevierStyleHsp" style=""></span>meq/l) with the data of 12 refractory CHF patients who were treated with icodextrin during the same period but their median serum sodium was 134.5<span class="elsevierStyleHsp" style=""></span>meq/l (range 132.3–136.7<span class="elsevierStyleHsp" style=""></span>meq/l). Higher SPAP was more likely connected to significant hyponatremia: median SPAP measured 78<span class="elsevierStyleHsp" style=""></span>mmHg (range 43–92<span class="elsevierStyleHsp" style=""></span>mmHg) in severe hyponatremia group compared to 49<span class="elsevierStyleHsp" style=""></span>mmHg (range 37–67<span class="elsevierStyleHsp" style=""></span>mmHg) in mild hyponatremia group (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.0225). Patients who developed significant hyponatremia died earlier compared to patients with insignificant hyponatremia. Median survival was 5 months (range 2–7 months) in severe hyponatremia group compared to 15.5 months (range 6–50 months) in mild hyponatremia group (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.0318). There was a tendency for significant sodium drop in women compared to men: in significant hyponatremia group 60% were women compared to 8% women in mild hyponatremia group (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.0525). Patients with lower baseline sodium showed a tendency for a more significant sodium drop compared to those with higher baseline sodium. Baseline serum sodium was 136.3<span class="elsevierStyleHsp" style=""></span>meq/l (range 133.7–137.3<span class="elsevierStyleHsp" style=""></span>meq/l) in the severe hyponatremia group compared to 138<span class="elsevierStyleHsp" style=""></span>meq/l (range 134.3–141<span class="elsevierStyleHsp" style=""></span>meq/l) in mild hyponatremia group (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.0854).</p><p id="par0050" class="elsevierStylePara elsevierViewall">There was no difference between the groups in NYHA functional class, diabetes mellitus rate, serum creatinine and albumin levels, baseline urinary sodium or diuretics use.</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Discussion</span><p id="par0055" class="elsevierStylePara elsevierViewall">We presented the group of patients who developed clinically relevant hyponatremia following icodextrin addition to the program. Five refractory CHF patients showed serum sodium drop by median of 8<span class="elsevierStyleHsp" style=""></span>meq/l during the first month of icodextrin treatment, more profound decrease than previously reported (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">11–13</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">It have been proposed that several mechanisms could explain the development of hyponatremia in PD, including net water gain due to excessive water intake or low ultrafiltration rate of free-water, negative Na+/K+ balance caused by low Na+/K+ intake or high Na+/K+ removal, and shift of intracellular water to extracellular space induced by the use of icodextrin or hypercatabolism and malnutrition.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">14</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">CHF patients had a tendency to low serum sodium level due to neurohumoral activation. The neurohumoral changes limit both sodium and water excretion in an attempt to return perfusion pressure to normal. ADH release directly enhances water reabsorption in the collecting tubules, whereas angiotensin II and norepinephrine limit distal water delivery by reduction in renal perfusion and by increasing proximal sodium and water reabsorption.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">15</span></a> In addition, both the low cardiac output and high angiotensin II levels are potent stimuli to thirst, leading to enhanced water intake. While significant hyponatremia was temporarily related to icodextrin start, we could not exclude the possibility that hyponatremia in these patients is multifactorial. Probably some our patients were non-adherent to free water restriction, while others demonstrated hyperglycemia (although corrected serum sodium was also low). Other possible contributors to hyponatremia in those patients are dietary restriction and chronic use of diuretics. The risk factors for hyponatremia were female sex, low initial sodium level and increased SPAP. All patients except one had hypertonic glucose 4.25% in their program which could increase thirst and as a result free water consumption. Perhaps, icodextrin metabolites accumulation rises serum osmolality, stimulates thirst and free water consumption which further contribute to hyponatremia in those severe CHF patients.</p><p id="par0070" class="elsevierStylePara elsevierViewall">In our cases patients with severe hyponatremia had lower survival compared to mild hyponatremia group. The studies demonstrated that severe underlying disease worsens hyponatremia and clinical outcome.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">14</span></a> Hyponatremia itself may be a surrogate marker for the severity of underlying disease.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">14</span></a> Hyponatremia is known to be an important marker and prognostic factor of left-sided heart failure.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">16</span></a> Recently, it was demonstrated that hyponatremia was an indicator of poor prognosis in patients with echocardiographic evidence of pulmonary hypertension and preserved left ventricular systolic function.<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">17</span></a> Perhaps, patients with certain heart failure etiologies and severe heart disease (as represented by lower survival rate compared to mild hyponatremia group) are more susceptible to this complication.</p><p id="par0075" class="elsevierStylePara elsevierViewall">Two CHF patients who developed significant hyponatremia following icodextrin treatment suffered from hip fracture. There is an emerging literature that suggests that hyponatremia increases the adjusted odds ratio for both falls and fractures in the elderly.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">18</span></a> Hyponatremia appears to contribute to falls and fractures by two mechanisms: it produces mild cognitive impairment resulting in unsteady gait and falls and it directly contributes to bone impairment through osteoporosis due to increased bone resorption in order to mobilize sodium from the bone or altered bone quality through decreased bone microfracture repair.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">18</span></a></p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Conclusions</span><p id="par0080" class="elsevierStylePara elsevierViewall">Hyponatremia in refractory CHF patients is multifactorial. In rare cases, icodextrin may contribute to clinically relevant hyponatremia if the hyponatremia is compounded by other factors. Severe hyponatremia in icodextrin users was associated with poorer survival and is most likely a marker of advanced heart disease. This could be a signal to physician to consider alternative and probably more aggressive interventions.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Conflict of interests</span><p id="par0085" class="elsevierStylePara elsevierViewall">The authors declare they have no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:11 [ 0 => array:3 [ "identificador" => "xres968897" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec939890" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres968898" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec939889" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Cases description" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Patient 1" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Patient 2" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Patient 3" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Patient 4" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "Patient 5" ] ] ] 6 => array:2 [ "identificador" => "sec0040" "titulo" => "Comparison of severe hyponatremia group with mild hyponatremia group" ] 7 => array:2 [ "identificador" => "sec0045" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0050" "titulo" => "Conclusions" ] 9 => array:2 [ "identificador" => "sec0055" "titulo" => "Conflict of interests" ] 10 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2016-11-21" "fechaAceptado" => "2017-05-02" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec939890" "palabras" => array:3 [ 0 => "Hyponatremia" 1 => "Congestive heart failure" 2 => "Peritoneal dialysis" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec939889" "palabras" => array:3 [ 0 => "Hiponatremia" 1 => "Insuficiencia cardíaca congestiva" 2 => "Diálisis peritoneal" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Severe congestive heart failure (CHF) patients are prone to hyponatremia. Peritoneal dialysis (PD) is increasingly used for long-term management of refractory CHF patients. The glucose polymer icodextrin was proposed to be a good option for fluid removal in such patients. A small, although statistically significant reduction in serum sodium (∼2<span class="elsevierStyleHsp" style=""></span>mmol/l) consistently observed in multiple trials, is considered as not clinically relevant. Here we reported five refractory CHF patients who demonstrated sodium drop by median of 8<span class="elsevierStyleHsp" style=""></span>meq/l (range 5.4–8.3<span class="elsevierStyleHsp" style=""></span>meq/l) after icodextrin was added to their program. It seems that icodextrin may contribute to clinically relevant hyponatremia if the hyponatremia is compounded by other factors. Patients with extremely severe congestive heart failure are susceptible to this complication.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Los pacientes con insuficiencia cardíaca congestiva grave son propensos a sufrir hiponatremia. La diálisis peritoneal se utiliza cada vez más para el tratamiento a largo plazo de los pacientes con insuficiencia cardíaca congestiva resistentes al tratamiento. El polímero de glucosa icodextrina se propuso como una buena opción para la ultrafiltración. Una reducción pequeña, aunque estadísticamente significativa, del sodio sérico (∼2<span class="elsevierStyleHsp" style=""></span>mmol/l) observada sistemáticamente en numerosos ensayos no se considera de relevancia clínica. En este documento informamos de 5 casos de pacientes con insuficiencia cardíaca congestiva resistentes al tratamiento que presentaron una caída de las concentraciones de sodio en una mediana de 8<span class="elsevierStyleHsp" style=""></span>mEq/l (intervalo 5,4-8,3<span class="elsevierStyleHsp" style=""></span>mEq/l) después de la adición de icodextrina a su programa. Parece ser que la icodextrina puede contribuir a una hiponatremia clínicamente relevante si se combina con otros factores. Los pacientes con insuficiencia cardíaca congestiva muy grave son propensos a esta complicación.</p></span>" ] ] "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Case 1 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Case 2 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Case 3 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Case 4 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Case 5 \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age, years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">63 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">64 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">82 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">75 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">85 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sex \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">f \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">f \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">m \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">f \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">m \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Etiology of heart disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Restrictive cardiomyopathy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hypertrophic cardiomyopathy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ischemic cardiomyopathy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Primary pulmonary hypertension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ischemic cardiomyopathy \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Etiology of renal disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Nephrosclerosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Cardiorenal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Nephrosclerosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Cardiorenal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Cardiorenal \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Diabetes mellitus \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yes \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Yes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Baseline serum sodium (meq/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">136.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">133.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">134.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">137.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">138.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Serum sodium (meq/l) 1 month after icodextrin start \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">128.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">126.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">129.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">129 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">130 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Serum glucose (mg/dL) 1 month after icodextrin start \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">160 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">114.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">192.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">118.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">232.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Baseline serum creatinine (mg/dL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.26 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.76 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.46 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.65 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Baseline serum albumin (g/dL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">LVEF (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">60 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">70 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Estimated SPAP (mmHg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">88 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">56 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">43 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">92 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">76 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Diuretics \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Furosemide \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Furosemide \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Furosemide \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Furosemide \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Other solutions (L/day) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.25% – 2<span class="elsevierStyleHsp" style=""></span>L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.5% - 6<span class="elsevierStyleHsp" style=""></span>L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.25% – 2<span class="elsevierStyleHsp" style=""></span>L<br>2.5% – 2<span class="elsevierStyleHsp" style=""></span>L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.25% – 2<span class="elsevierStyleHsp" style=""></span>L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.25% – 2<span class="elsevierStyleHsp" style=""></span>L \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Clinical symptoms \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Restlessness, muscle weakness \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Confusion \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Confusion,<br>hip fracture<br> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Confusion, hip fracture \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Weakness, fatigue \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1639300.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Cases of severe hyponatremia following icodextrin treatment.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:18 [ 0 => array:3 [ "identificador" => "bib0095" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Peritoneal dialysis for chronic congestive heart failure" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K. François" 1 => "C. Ronco" 2 => "J.M. Bargman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000430084" "Revista" => array:6 [ "tituloSerie" => "Blood Purif" "fecha" => "2015" "volumen" => "40" "paginaInicial" => "45" "paginaFinal" => "52" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26111872" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0100" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Lu" 1 => "M.J. Muciño-Bermejo" 2 => "L.C. Ribeiro" 3 => "E. Tonini" 4 => "C. Estremadoyro" 5 => "S. Samoni" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000380915" "Revista" => array:6 [ "tituloSerie" => "Cardiorenal Med" "fecha" => "2015" "volumen" => "5" "paginaInicial" => "145" "paginaFinal" => "156" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25999963" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0105" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Basile" 1 => "D. Chimienti" 2 => "A. Bruno" 3 => "S. Cocola" 4 => "P. Libutti" 5 => "A. Teutonico" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Perit Dial Int" "fecha" => "2009" "volumen" => "29" "paginaInicial" => "116" "paginaFinal" => "118" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19164263" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0110" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Peritoneal ultrafiltration in refractory heart failure: a cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.V. Bertoli" 1 => "C. Musetti" 2 => "D. Ciurlino" 3 => "C. Basile" 4 => "E. Galli" 5 => "G. Gambaro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3747/pdi.2012.00290" "Revista" => array:6 [ "tituloSerie" => "Perit Dial Int" "fecha" => "2014" "volumen" => "34" "paginaInicial" => "64" "paginaFinal" => "70" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24179103" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0115" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Two daytime icodextrin exchanges decrease brain natriuretic peptide levels and improve cardiac functions in continuous ambulatory peritoneal dialysis patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "T. Sav" 1 => "M.T. Inanc" 2 => "A. Dogan" 3 => "O. Oymak" 4 => "C. Utas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Nephrology (Carlton)" "fecha" => "2010" "volumen" => "15" "paginaInicial" => "307" "paginaFinal" => "312" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0120" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T. Sav" 1 => "O. Oymak" 2 => "M.T. Inanc" 3 => "A. Dogan" 4 => "B. Tokgoz" 5 => "C. Utas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Perit Dial Int" "fecha" => "2009" "volumen" => "29" "paginaInicial" => "443" "paginaFinal" => "449" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19602610" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0125" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Peritoneal ultrafiltration in congestive heart failure-findings reported from its application in clinical practice: a systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G. Viglino" 1 => "L. Neri" 2 => "M. Feola" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s40620-014-0166-9" "Revista" => array:6 [ "tituloSerie" => "J Nephrol" "fecha" => "2015" "volumen" => "28" "paginaInicial" => "29" "paginaFinal" => "38" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25585824" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0130" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Practical considerations when prescribing icodextrin: a narrative review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.A. Silver" 1 => "Z. Harel" 2 => "J. Perl" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000363417" "Revista" => array:6 [ "tituloSerie" => "Am J Nephrol" "fecha" => "2014" "volumen" => "39" "paginaInicial" => "515" "paginaFinal" => "527" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24925229" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0135" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Peritoneal dialysis: new developments and new problems" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C.W. Gradden" 1 => "R. Ahmad" 2 => "G.M. Bell" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Diabet Med" "fecha" => "2001" "volumen" => "18" "paginaInicial" => "360" "paginaFinal" => "363" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11472445" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0165037815000273" "estado" => "S300" "issn" => "01650378" ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0140" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sodium removal in patients undergoing CAPD and automated peritoneal dialysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Rodriguez-Carmona" 1 => "M.P. Fontán" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Perit Dial Int" "fecha" => "2002" "volumen" => "22" "paginaInicial" => "705" "paginaFinal" => "713" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12556073" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0145" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomised multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "the MIDAS Study Group" "etal" => false "autores" => array:3 [ 0 => "C. Mistry" 1 => "R. Gokal" 2 => "E.M. Peers" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Kidney Int" "fecha" => "1994" "volumen" => "46" "paginaInicial" => "496" "paginaFinal" => "503" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7967363" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0150" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "21" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "N. Posthuma" 1 => "P.M. ter Wee" 2 => "A.J.M. Donker" 3 => "P.L. Oe" 4 => "W. van Dorp" 5 => "H.A. Verbrugh" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Perit Dial Int" "fecha" => "1997" "volumen" => "6" "paginaInicial" => "602" "paginaFinal" => "607" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0155" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Wolfson" 1 => "B. Piraino" 2 => "R.J. Hamburger" 3 => "A.R. Morton" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/ajkd.2002.36344" "Revista" => array:6 [ "tituloSerie" => "Am J Kidney Dis" "fecha" => "2002" "volumen" => "40" "paginaInicial" => "1055" "paginaFinal" => "1065" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12407652" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0160" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia is a surrogate marker of poor outcome in peritoneal dialysis-related peritonitis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.H. Tseng" 1 => "C.J. Cheng" 2 => "C.C. Sung" 3 => "Y.C. Chou" 4 => "P. Chu" 5 => "G.S. Chen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1471-2369-15-113" "Revista" => array:5 [ "tituloSerie" => "BMC Nephrol" "fecha" => "2014" "volumen" => "15" "paginaInicial" => "113" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25012614" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0165" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyponatremia in acute decompensated heart failure: depletion versus dilution" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "F.H. Verbrugge" 1 => "P. Steels" 2 => "L. Grieten" 3 => "P. Nijst" 4 => "W.H. Tang" 5 => "W. Mullens" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2014.12.010" "Revista" => array:7 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2015" "volumen" => "65" "paginaInicial" => "480" "paginaFinal" => "492" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25660927" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0165037809002599" "estado" => "S300" "issn" => "01650378" ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0170" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "W.H. Lee" 1 => "M. Packer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "1986" "volumen" => "73" "paginaInicial" => "257" "paginaFinal" => "267" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3002660" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0175" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of hyponatremia and outcomes in pulmonary hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Rabinovitz" 1 => "F. Raiszadeh" 2 => "R. Zolty" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cardfail.2013.05.014" "Revista" => array:6 [ "tituloSerie" => "J Card Fail" "fecha" => "2013" "volumen" => "19" "paginaInicial" => "550" "paginaFinal" => "556" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23910584" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0180" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Is chronic hyponatremia a novel risk factor for hip fracture in the elderly?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.C. Ayus" 1 => "A.L. Negri" 2 => "K. Kalantar-Zadeh" 3 => "M.L. Moritz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfs412" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "2012" "volumen" => "27" "paginaInicial" => "3725" "paginaFinal" => "3731" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23114899" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/02116995/0000003800000001/v1_201801090621/S0211699517301339/v1_201801090621/en/main.assets" "Apartado" => array:4 [ "identificador" => "45482" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Caso clínico" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/02116995/0000003800000001/v1_201801090621/S0211699517301339/v1_201801090621/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699517301339?idApp=UINPBA000064" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 9 | 8 | 17 |
2024 Octubre | 60 | 51 | 111 |
2024 Septiembre | 60 | 39 | 99 |
2024 Agosto | 106 | 68 | 174 |
2024 Julio | 60 | 45 | 105 |
2024 Junio | 78 | 50 | 128 |
2024 Mayo | 113 | 49 | 162 |
2024 Abril | 87 | 37 | 124 |
2024 Marzo | 77 | 25 | 102 |
2024 Febrero | 52 | 40 | 92 |
2024 Enero | 62 | 25 | 87 |
2023 Diciembre | 66 | 20 | 86 |
2023 Noviembre | 89 | 31 | 120 |
2023 Octubre | 153 | 36 | 189 |
2023 Septiembre | 313 | 26 | 339 |
2023 Agosto | 215 | 29 | 244 |
2023 Julio | 76 | 33 | 109 |
2023 Junio | 122 | 30 | 152 |
2023 Mayo | 129 | 42 | 171 |
2023 Abril | 88 | 41 | 129 |
2023 Marzo | 133 | 28 | 161 |
2023 Febrero | 104 | 26 | 130 |
2023 Enero | 68 | 34 | 102 |
2022 Diciembre | 107 | 52 | 159 |
2022 Noviembre | 93 | 43 | 136 |
2022 Octubre | 151 | 79 | 230 |
2022 Septiembre | 84 | 57 | 141 |
2022 Agosto | 61 | 52 | 113 |
2022 Julio | 69 | 64 | 133 |
2022 Junio | 104 | 70 | 174 |
2022 Mayo | 129 | 42 | 171 |
2022 Abril | 180 | 74 | 254 |
2022 Marzo | 114 | 69 | 183 |
2022 Febrero | 66 | 52 | 118 |
2022 Enero | 57 | 55 | 112 |
2021 Diciembre | 61 | 52 | 113 |
2021 Noviembre | 99 | 43 | 142 |
2021 Octubre | 150 | 60 | 210 |
2021 Septiembre | 47 | 42 | 89 |
2021 Agosto | 46 | 51 | 97 |
2021 Julio | 53 | 41 | 94 |
2021 Junio | 51 | 50 | 101 |
2021 Mayo | 81 | 55 | 136 |
2021 Abril | 162 | 96 | 258 |
2021 Marzo | 236 | 67 | 303 |
2021 Febrero | 93 | 38 | 131 |
2021 Enero | 73 | 39 | 112 |
2020 Diciembre | 77 | 25 | 102 |
2020 Noviembre | 42 | 29 | 71 |
2020 Octubre | 47 | 40 | 87 |
2020 Septiembre | 48 | 34 | 82 |
2020 Agosto | 47 | 28 | 75 |
2020 Julio | 85 | 37 | 122 |
2020 Junio | 62 | 33 | 95 |
2020 Mayo | 83 | 14 | 97 |
2020 Abril | 60 | 31 | 91 |
2020 Marzo | 64 | 21 | 85 |
2020 Febrero | 84 | 24 | 108 |
2020 Enero | 81 | 48 | 129 |
2019 Diciembre | 87 | 33 | 120 |
2019 Noviembre | 58 | 33 | 91 |
2019 Octubre | 78 | 37 | 115 |
2019 Septiembre | 60 | 29 | 89 |
2019 Agosto | 55 | 32 | 87 |
2019 Julio | 48 | 21 | 69 |
2019 Junio | 67 | 27 | 94 |
2019 Mayo | 55 | 24 | 79 |
2019 Abril | 101 | 52 | 153 |
2019 Marzo | 71 | 43 | 114 |
2019 Febrero | 42 | 28 | 70 |
2019 Enero | 42 | 49 | 91 |
2018 Diciembre | 212 | 69 | 281 |
2018 Noviembre | 317 | 52 | 369 |
2018 Octubre | 173 | 20 | 193 |
2018 Septiembre | 147 | 39 | 186 |
2018 Agosto | 137 | 28 | 165 |
2018 Julio | 79 | 25 | 104 |
2018 Junio | 81 | 29 | 110 |
2018 Mayo | 100 | 18 | 118 |
2018 Abril | 152 | 18 | 170 |
2018 Marzo | 155 | 18 | 173 |
2018 Febrero | 254 | 10 | 264 |
2018 Enero | 167 | 16 | 183 |
2017 Diciembre | 132 | 18 | 150 |
2017 Noviembre | 97 | 23 | 120 |
2017 Octubre | 84 | 17 | 101 |
2017 Septiembre | 113 | 25 | 138 |
2017 Agosto | 92 | 19 | 111 |
2017 Julio | 7 | 2 | 9 |